Endocrine Society Applauds Eli Lilly’s Efforts to Lower Insulin Costs

March 1, 2023

Monthly price caps should be available to everyone who depends on insulin The Endocrine Society commends Eli Lilly and Company for taking steps to reduce insulin prices and make insulin affordable for more people with diabetes. Eli Lilly’s announcement to cut insulin prices by 70% and extend the $35 per month insulin cap to people […]

To view the full Member Resource, please Log in

TOPICS IN THIS ARTICLE:

Society News

Join the Global Movement Advancing Endocrine Science and Medicine

Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.

Join Today

RELATED ARTICLES

Looking Back: Unforgettable Moments from ENDOs Past

Endocrine Society Endorses Bipartisan Bill to Address Insulin Affordability

In Memoriam: Martin Savage 1941-2026

Health Topics

Patient Populations